Skip to content
Clinical Trials – home
NorwayBack to Norway

Clinical trials in Skedsmokorset – page 24

607 clinical trials in Skedsmokorset, Norway. Every trial is listed in the EU Clinical Trials Register and updated daily.

NorwayOur site in NorwayKliniske-Studier.no(opens in a new tab)
Skedsmokorset at a glance
607
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

607 trials in Skedsmokorset

Open in trial search

Study of Ambroxol Treatment in People with Early Stage or Mild Lewy Body Dementia

Investigational
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Ambroxol Hydrochloride
  • Sponsor:Helse Fonna HF

Neoplasm

Recruiting

Study on Long-Term Safety of BI 907828 for Patients with Solid Tumors Who Previously Participated in a Study with This Medicine

InvestigationalNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Brigimadlin
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study of Dasatinib and Venetoclax for Children with Relapsed or Refractory Leukemia or Lymphoma with MAPK/SRC Pathway Mutation

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years
  • Substances:Dasatinib
  • Sponsor:Prinses Maxima Centrum voor Kinderoncologie B.V.

Study on the Effects of Filgotinib for Children and Teenagers with Moderate to Severe Ulcerative Colitis

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:0–17 years
  • Substances:Filgotinib
  • Sponsor:Alfasigma S.p.A.

Crohn's disease

Recruiting

Study of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn's Disease

InvestigationalNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:ABBV-8736
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Aortic valve stenosis

Not yet recruiting

A Phase 2b/3 Randomized Double‑Blind Study of Ataciguat to Slow Disease Progression in Adults with Moderate Calcific Aortic Valve Stenosis

Investigational
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Ataciguat
  • Sponsor:Kardigan Inc.

Systemic scleroderma+1

Not yet recruiting

Study of Amlitelimab and BI 1015550 for Patients with Interstitial Lung Disease Due to Scleroderma

Investigational
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Amlitelimab
  • Sponsor:Scleroderma Research Foundation

Oxaliplatin-based drug combination (including bevacizumab, tislelizumab, fluorouracil, folic acid) for patients with diagnosed metastatic colorectal cancer

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Akershus University Hospital

Multifocal motor neuropathy

Not yet recruiting

Phase 1b study of empasiprubart in adults with multifocal motor neuropathy to assess nerve morphology by ultrasound

InvestigationalNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Empasiprubart
  • Sponsor:Argenx

Ischaemic stroke

Not yet recruiting

A study to evaluate the use of tocilizumab in adults with acute ischemic stroke undergoing mechanical clot removal.

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Oslo University Hospital HF

Adenocarcinoma pancreas

Not yet recruiting

First‑Line Study of Zoldonrasib (RMC‑9805) Drug Combination vs Gemcitabine/Nab‑Paclitaxel in Patients with Metastatic KRAS G12D‑Mutated Pancreatic Cancer

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Daraxonrasib
  • Sponsor:Revolution Medicines Inc.

Plasma cell myeloma

Not yet recruiting

A Phase III Study of AZD0120 versus melphalan hydrochloride with lenalidomide maintenance in transplant‑eligible adults with newly diagnosed multiple myeloma

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:AZD0120
  • Sponsor:AstraZeneca AB

Other cities in Norway

The busiest research cities in the country

All 53 cities in Norway

Clinical research in Skedsmokorset

What the registry says about research in the country

01 Cardiovascular Research

Innovative clinical trials focusing on lipoprotein management and prevention of major cardiovascular events in patients with established cardiovascular disease.

  • Cardiovascular Disease Prevention
  • Lipid Management
  • Cardiovascular Event Reduction

Studies evaluating novel therapeutic approaches for reducing cardiovascular mortality and improving patient outcomes.

02 Stroke Prevention

Research examining new treatments for preventing stroke and systemic embolism in patients with atrial fibrillation, comparing innovative therapies with established medications.

  • Atrial Fibrillation Management
  • Anticoagulation Therapy
  • Stroke Risk Reduction

Trials focused on developing safer and more effective treatments for stroke prevention.

03 Vascular Disease Research

Studies investigating treatments for atherosclerotic cardiovascular disease, with emphasis on preventing major adverse cardiovascular events.

  • ASCVD Management
  • Cardiovascular Risk Reduction
  • LDL cholesterol Control

Evaluation of novel therapies targeting established vascular disease and its complications.

04 Pulmonary Medicine

Clinical research examining the effectiveness of combination therapies for Chronic Obstructive Pulmonary Disease, focusing on cardiopulmonary outcomes.

  • COPD Treatment
  • Respiratory Medicine
  • Bronchodilator Therapy

Investigation of advanced treatment options for improving respiratory function and quality of life.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.